Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMCR Immunocore Holdings plc

交易中 08-05 10:53:56 EDT

32.60

-0.64

-1.94%

最高33.49	最低32.35	成交量9.94万
今开33.34	昨收33.24	日振幅3.43%
总市值16.57亿	流通市值13.84亿	总股本5,083万
成交额326.93万	换手率0.23%	流通股本4,246万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMCR","market":"US","secType":"STK","nameCN":"Immunocore Holdings plc","latestPrice":32.595,"timestamp":1785941625229,"preClose":33.24,"halted":0,"volume":99393,"delay":0,"changeRate":-0.01940433212996399,"floatShares":42460800,"shares":50831928,"eps":-0.545724,"marketStatus":"交易中","change":-0.645,"latestTime":"08-05 10:53:56 EDT","open":33.34,"high":33.49,"low":32.35,"amount":3269325.4012019997,"amplitude":0.034296,"askPrice":32.66,"askSize":301,"bidPrice":32.48,"bidSize":8,"shortable":3,"etf":0,"ttmEps":-0.545724,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1785960000000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":33.24,"preHourTrading":{"tag":"盘前","latestPrice":33.6,"preClose":33.24,"latestTime":"08:57 EDT","volume":5,"amount":167.99,"timestamp":1785934654767,"change":0.36,"changeRate":0.01083,"amplitude":0.000301},"postHourTrading":{"tag":"盘后","latestPrice":33.24,"preClose":33.24,"latestTime":"19:34 EDT","volume":1457,"amount":48430.68,"timestamp":1785886445412,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.965783,"impliedVol":0.5779,"impliedVolPercentile":0.8367},"requestUrl":"/m/hq/s/IMCR","defaultTab":"news","newsList":[{"id":"1160132858","title":"财报前瞻｜Immunocore Holdings plc本季度营收预计增16.31%，机构观点偏多看涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1160132858","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160132858?lang=zh_cn&edition=full","pubTime":"2026-07-31 03:04","pubTimestamp":1785438294,"startTime":"0","endTime":"0","summary":"Immunocore Holdings plc将于2026年08月06日美股盘前发布最新季度财报，市场关注营收与盈利质量的边际变化。上季度公司实现营收1.07亿美元，同比增长13.63%；毛利率99.59%；归属于母公司股东的净利润为1,297.10万美元，净利率12.16%，环比增长率为143.15%；调整后每股收益为0.25美元，同比增长150.00%。结合本季度一致预期营收增长16.31%，市场隐含假设是核心产品处方新增与持续治疗周期延长共同驱动。综合近半年主流研报与机构评论，对Immunocore Holdings plc的观点以看涨为主，占比更高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Immunocore Holdings plc本季度营收预计增16.31%，机构观点偏多看涨","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180194128","title":"Immunocore将于2025年2月25日公布2025年第四季度及全年财报并举行电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1180194128","media":"投资观察","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180194128?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:06","pubTimestamp":1771416375,"startTime":"0","endTime":"0","summary":"Immunocore Holdings plc今日宣布，将于2026年2月25日（星期三）公布其截至2025年12月31日的第四季度及全年财务业绩。此次电话会议将进行网络直播，听众可通过访问Immunocore公司官网的\"投资者\"栏目，进入\"活动与演示\"下的\"活动\"部分来参与。Immunocore是一家处于商业化阶段的生物技术公司，致力于开创并开发一类名为ImmTAX的新型TCR双特异性免疫疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516487515","title":"Immunocore Hldgs Plc2024财年实现净利润-51.11百万美元，同比增加7.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516487515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516487515?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:00","pubTimestamp":1740931237,"startTime":"0","endTime":"0","summary":"3月3日，Immunocore Hldgs Plc公布财报，公告显示公司2024财年净利润为-51.11百万美元，同比增加7.91%；其中营业收入为3.10亿美元，同比增加24.00%，每股基本收益为-1.02美元。从资产负债表来看，Immunocore Hldgs Plc总负债6.49亿美元，其中短期债务1.55百万美元，资产负债比为1.56，流动比率为4.39。机构评级：截至2025年3月3日，当前有14家机构对Immunocore Hldgs Plc目标价做出预测，其中目标均价为65.19美元，其中最低目标价为23.59美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000057a25bbc39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000057a25bbc39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514629850","title":"Immunocore Hldgs Plc盘中异动 临近午盘大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514629850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514629850?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:33","pubTimestamp":1740587597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时33分，Immunocore Hldgs Plc股票出现波动，股价急速拉升5.17%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为0.03%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003317abde0912&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003317abde0912&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","IMCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180521302","title":"Immunocore Hldgs第四季度每股收益$(0.47) 低于预期$(0.24)，销售额$84.05M 超过预期$83.55M","url":"https://stock-news.laohu8.com/highlight/detail?id=1180521302","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180521302?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:07","pubTimestamp":1740571668,"startTime":"0","endTime":"0","summary":"Immunocore Hldgs 报告季度每股亏损$，低于分析师一致预期的$，差距为95.83%。与去年同期每股亏损$相比，这一数据减少了17.5%。公司报告季度销售额为$84.05M，高于分析师一致预期的$83.55M，增幅为0.60%。以上内容来自Benzinga Earnings专栏，原文如下：Immunocore Hldgs  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 95.83 percent. This is a 17.5 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $84.05 million which beat the analyst consensus estimate of $83.55 million by 0.60 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Immunocore Hldgs第四季度每股收益$(0.47) 低于预期$(0.24)，销售额$84.05M 超过预期$83.55M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505044313","title":"Immunocore Hldgs Plc盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505044313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505044313?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:48","pubTimestamp":1737654536,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时48分，Immunocore Hldgs Plc股票出现波动，股价快速上涨5.03%。截至发稿，该股报32.58美元/股，成交量16.9687万股，换手率0.34%，振幅5.83%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.91%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124014856a22d316c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124014856a22d316c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505583272","title":"Immunocore Hldgs Plc盘中异动 急速拉升6.79%报30.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505583272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505583272?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:49","pubTimestamp":1737470958,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时49分，Immunocore Hldgs Plc股票出现波动，股价大幅拉升6.79%。截至发稿，该股报30.99美元/股，成交量5410股，换手率0.01%，振幅0.00%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为1.20%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224919abb34b89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224919abb34b89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640392","title":"Immunocore Hldgs Plc盘中异动 早盘快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640392?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951551,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Immunocore Hldgs Plc股票出现异动，股价急速拉升5.01%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、54.43%、35.46%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223232ababf290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223232ababf290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMCR","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503686008","title":"Immunocore Hldgs Plc盘中异动 下午盘大幅下挫5.09%报28.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503686008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503686008?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:21","pubTimestamp":1736886115,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时21分，Immunocore Hldgs Plc股票出现异动，股价快速跳水5.09%。截至发稿，该股报28.50美元/股，成交量23.2577万股，换手率0.46%，振幅5.47%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为1.35%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504215598663b99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504215598663b99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501736385","title":"Immunocore Hldgs Plc盘中异动 快速上涨5.16%报31.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501736385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501736385?lang=zh_cn&edition=full","pubTime":"2025-01-08 02:28","pubTimestamp":1736274511,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日02时28分，Immunocore Hldgs Plc股票出现异动，股价大幅上涨5.16%。截至发稿，该股报31.41美元/股，成交量10.2133万股，换手率0.20%，振幅4.62%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为1.31%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108022832a219185b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108022832a219185b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMCR","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494897547","title":"Immunocore Hldgs Plc盘中异动 大幅拉升5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494897547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494897547?lang=zh_cn&edition=full","pubTime":"2024-12-27 04:30","pubTimestamp":1735245002,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日04时30分，Immunocore Hldgs Plc股票出现波动，股价大幅拉升5.62%。截至发稿，该股报30.27美元/股，成交量25.6057万股，换手率0.51%，振幅6.32%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.38%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122704300298508c3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122704300298508c3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492915378","title":"Immunocore Hldgs Plc盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492915378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492915378?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:54","pubTimestamp":1734551668,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时54分，Immunocore Hldgs Plc股票出现异动，股价大幅下跌5.07%。截至发稿，该股报27.91美元/股，成交量14.3862万股，换手率0.29%，振幅5.82%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为1.95%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903542995ea5992&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903542995ea5992&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMCR","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491305486","title":"Immunocore Hldgs Plc盘中异动 大幅跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491305486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491305486?lang=zh_cn&edition=full","pubTime":"2024-12-14 01:25","pubTimestamp":1734110725,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时25分，Immunocore Hldgs Plc股票出现异动，股价快速跳水5.01%。截至发稿，该股报28.79美元/股，成交量14.2609万股，换手率0.29%，振幅3.40%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为0.62%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121401252595e97ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121401252595e97ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490897109","title":"Immunocore Hldgs Plc盘中异动 股价大跌5.15%报30.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490897109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490897109?lang=zh_cn&edition=full","pubTime":"2024-12-12 04:30","pubTimestamp":1733949048,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日04时30分，Immunocore Hldgs Plc股票出现波动，股价大幅下挫5.15%。截至发稿，该股报30.21美元/股，成交量15.395万股，换手率0.31%，振幅5.79%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为0.25%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212043048a1e70f62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212043048a1e70f62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","BK4539","BK4505","BK4139","IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486033208","title":"Immunocore Hldgs Plc盘中异动 早盘大幅上涨5.15%报33.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486033208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486033208?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:02","pubTimestamp":1732546973,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时02分，Immunocore Hldgs Plc股票出现异动，股价急速上涨5.15%。截至发稿，该股报33.94美元/股，成交量9071股，换手率0.02%，振幅3.90%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为1.73%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112523025498e446cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112523025498e446cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484924319","title":"Immunocore Hldgs Plc盘中异动 早盘大幅上涨5.15%报32.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484924319?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:07","pubTimestamp":1732032432,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时07分，Immunocore Hldgs Plc股票出现异动，股价大幅上涨5.15%。截至发稿，该股报32.65美元/股，成交量3.4333万股，换手率0.07%，振幅6.96%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为0.72%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000071398e438c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000071398e438c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482832087","title":"Immunocore Hldgs Plc盘中异动 大幅下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482832087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482832087?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:34","pubTimestamp":1731425662,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时34分，Immunocore Hldgs Plc股票出现异动，股价快速跳水5.08%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为0.31%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112233422971a60e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112233422971a60e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","IMCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482173239","title":"Immunocore Hldgs Plc2024财年第三财季实现净利润8.83百万美元，同比增加266.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482173239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482173239?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:00","pubTimestamp":1731340832,"startTime":"0","endTime":"0","summary":"11月12日，Immunocore Hldgs Plc公布财报，公告显示公司2024财年第三财季净利润为8.83百万美元，同比增加266.39%；其中营业收入为81.07百万美元，同比增加24.42%，每股基本收益为0.18美元。从资产负债表来看，Immunocore Hldgs Plc总负债7.07亿美元，其中短期债务49.30百万美元，资产负债比为1.54，流动比率为3.79。机构评级：截至2024年11月12日，当前有15家机构对Immunocore Hldgs Plc目标价做出预测，其中目标均价为70.24美元，其中最低目标价为18.58美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000042abb68bbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000042abb68bbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481665608","title":"Immunocore Hldgs Plc盘中异动 股价大涨5.04%报32.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481665608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481665608?lang=zh_cn&edition=full","pubTime":"2024-11-06 05:00","pubTimestamp":1730840421,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日05时00分，Immunocore Hldgs Plc股票出现波动，股价急速拉升5.04%。截至发稿，该股报32.74美元/股，成交量15.8404万股，换手率0.32%，振幅7.78%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为1.65%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110605002198e40a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110605002198e40a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","IMCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2478761486","title":"Immunocore Hldgs Plc盘中异动 快速拉升5.12%报34.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478761486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478761486?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:45","pubTimestamp":1730123130,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时45分，Immunocore Hldgs Plc股票出现异动，股价大幅拉升5.12%。截至发稿，该股报34.48美元/股，成交量1.4021万股，换手率0.03%，振幅3.90%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体涨幅为0.45%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家后期生物技术公司，致力于开发用于治疗癌症，传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214530a1f254da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214530a1f254da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunocore.com","stockEarnings":[{"period":"1week","weight":-0.0081},{"period":"1month","weight":0.0228},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.075},{"period":"1year","weight":0.0218},{"period":"ytd","weight":-0.0424}],"compareEarnings":[{"period":"1week","weight":0.0411},{"period":"1month","weight":0.0356},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.2221},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunocore Holdings plc根据英格兰和威尔士法律于2021年1月7日成立。该公司是一家商业阶段的生物技术公司，开创并提供变革性免疫调节药物，从根本上改善癌症、传染病和自身免疫性疾病患者的预后。利用公司专有、灵活、现成的ImmTAX平台，该公司正在多个治疗领域开发深度管道，包括肿瘤学和传染病的临床阶段项目、自身免疫性疾病的先进临床前项目以及跨越三个治疗领域的早期临床前项目。2022年，公司获得FDA、欧盟委员会和卫生当局批准的用于治疗不可切除或转移性葡萄膜黑色素瘤的先导产品KIMMTRAK。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.031356},{"month":2,"riseRate":0,"avgChangeRate":-0.062034},{"month":3,"riseRate":0.333333,"avgChangeRate":0.007534},{"month":4,"riseRate":0.5,"avgChangeRate":0.010332},{"month":5,"riseRate":0.5,"avgChangeRate":-0.014019},{"month":6,"riseRate":0.5,"avgChangeRate":0.000567},{"month":7,"riseRate":0.833333,"avgChangeRate":0.07593},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.012706},{"month":9,"riseRate":0.4,"avgChangeRate":-0.024202},{"month":10,"riseRate":0.4,"avgChangeRate":0.002617},{"month":11,"riseRate":0.8,"avgChangeRate":0.095366},{"month":12,"riseRate":0.2,"avgChangeRate":-0.012917}],"exchange":"NASDAQ","name":"Immunocore Holdings plc","nameEN":"Immunocore Holdings plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunocore Holdings plc(IMCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunocore Holdings plc,IMCR,Immunocore Holdings plc股票,Immunocore Holdings plc股票老虎,Immunocore Holdings plc股票老虎国际,Immunocore Holdings plc行情,Immunocore Holdings plc股票行情,Immunocore Holdings plc股价,Immunocore Holdings plc股市,Immunocore Holdings plc股票价格,Immunocore Holdings plc股票交易,Immunocore Holdings plc股票购买,Immunocore Holdings plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunocore Holdings plc(IMCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}